Search for: "Courtenay Brinckerhoff" Results 61 - 80 of 92
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Oct 2011, 4:27 pm by Colin O'Keefe
Patent Applications - Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm's blog, PharmaPatents Meanwhile, The Number of Failed Banks Continues to Mount - Ohio attorney Kevin LaCroix of OakBridge Insurance Services in his blog, The D & O Diary [read post]
20 Oct 2011, 2:00 am by Stefanie Levine
The following analysis of  the new 35 USC § 102(a)(2) provision in the Leahy-Smith America Invents Act eliminating the Hilmer doctrine and giving prior art effect to U.S. patent applications as of their foreign filing dates comes from Courtenay Brinckerhoff ,writer of PharmaPatents Blog and Partner at Foley & Lardner. [read post]
20 Oct 2011, 2:00 am by Stefanie Levine
The following analysis of  the new 35 USC § 102(a)(2) provision in the Leahy-Smith America Invents Act eliminating the Hilmer doctrine and giving prior art effect to U.S. patent applications as of their foreign filing dates comes from Courtenay Brinckerhoff ,writer of PharmaPatents Blog and Partner at Foley & Lardner. [read post]
26 Sep 2011, 9:11 am by Stefanie Levine
 Courtenay Brinckerhoff, writer of PharmaPatents Blog and Partner at Foley & Lardner, posted an article setting forth details of the program including: applications eligible For Track I Examination, the filing requirements for Track I Examination, the on-going requirements for Track I Examination, the USPTO’s Track I goals and her lingering concerns. [read post]
26 Sep 2011, 9:11 am by Stefanie Levine
 Courtenay Brinckerhoff, writer of PharmaPatents Blog and Partner at Foley & Lardner, posted an article setting forth details of the program including: applications eligible For Track I Examination, the filing requirements for Track I Examination, the on-going requirements for Track I Examination, the USPTO’s Track I goals and her lingering concerns. [read post]
20 Sep 2011, 5:05 pm by Colin O'Keefe
Develop Your Next Generation of Rainmakers - Dallas, Texas attorney coach Cordell Parvin on the Cordell Parvin Blog The Shrill and the Marginal: The Left's Criticism of the Media - Patrick Maines, President of The Media Institute, at the Institute's Media & Communications Policy Blog When Being First-To-File Is Not Enough - Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm's blog, PharmaPatents [read post]
15 Sep 2011, 4:22 pm by Colin O'Keefe
Today isn't entirely without some commentary on the America Invents Act as we continue to see Foley & Lardner's Courtenay Brinckerhoff cover that topic like the gray clouds blanketing Seattle but, for a change of pace, the biggest story today is the FTC's proposed changes to the Children’s Online Privacy Protection Rule; Nicole Friess and Andy Serwin have the story. [read post]
28 Jul 2011, 4:39 pm by Colin O'Keefe
- Dallas non-compete lawyer Rob Radcliff on his Smooth Transitions Law Blog FiOS case update: trial nears conclusion, pre-suit damages ruling issued - Intellectual property attorney Joshua Heslinga on Troutman Sanders’ Virginia IP Law NLRB: Not All Employee Facebook Posts Deserve Protection After All - Hartford lawyer Daniel Schwartz of Pullman & Comley in his Connecticut Employment Law Blog Insight from Other Strategists - Sun Tzu on Terrain - Virginia attorney Andrew… [read post]
4 Apr 2011, 8:36 pm by Lawrence B. Ebert
Or, as attorney Courtenay Brinckerhoff, a partner with the law firm Foley and Lardner, posed the question in a statement: "Can Myriad explain the difference between patenting isolated DNA and patenting a leaf that has fallen off of a tree? [read post]
29 Mar 2011, 9:55 pm by Patent Docs
Donald Zuhn of McDonnell Boehnen Hulbert & Berghoff LLP will moderate panel including Courtenay Brinckerhoff of Foley & Lardner LLP and Dr. [read post]
24 Mar 2011, 2:35 am
Of late, Editor Courtenay Brinckerhoff has been discussing patent reform, human antibody claims, license agreements, and "definiteness. [read post]